Leveraging lab data to operationalize clinical trials can significantly streamline the development and recruitment process, not to mention lowering overall costs and accelerating time-to-market for new drugs and treatments. What’s that worth? Considering that every day of a patent life is a million dollar win for pharma, quite a lot.
Using lab data, combined with other data sources, also increases screening accuracy, helping to identify candidates most likely to clear trial inclusion/exclusion criteria. Since 60% of patients who express interest in a clinical trial ultimately fail to qualify, this is a big efficiency gain, especially balanced against the cost of prescreening, where 50% of the budget has already been committed to patient outreach.
What about the quality of clinical lab data when it comes to decision-making? When lab data is combined with claims, it gives researchers a window into diagnostic history, as well as patient procedures. Lab data is also the common language of physicians and, given the longitudinal view, enables researchers to see how values change, both independently and in concert with other values.
Indeed, 70% of clinical decisions are made, at least in part, on clinical lab data results.
When relying on lab data, expertise and a robust database are of critical importance. Quest is a trusted partner with experience and capabilities in data, analytics, and services across the trial development continuum, leveraging a database with more than 58+ billion clinical lab results in our database, as well as 2,250 patient service centers.